Uber WP

News

FDA grants clearance to Gilead Sciences’ sNDA for Veklury

The label has been updated to reflect that no dose adjustment is required in all stages of liver disease.

Features

Cybersecurity in pharma: Securing the future

News

US FDA approves Regeneron-Sanofi’s Kevzara to treat polymyalgia rheumatica

Opinion

Opinion: Lesser-known Western companies in Russia are avoiding political action

Sign up to the newsletter: In Brief

Your corporate email address *

First name *

Last name *

Company name *

Job title *

I would also like to subscribe to:

Pharma Technology Focus : Focus (monthly)

Thematic Take (monthly)

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close

FDA grants clearance to Gilead Sciences’ sNDA for Veklury

Cybersecurity in pharma: Securing the future

US FDA approves Regeneron-Sanofi’s Kevzara to treat polymyalgia rheumatica

Opinion: Lesser-known Western companies in Russia are avoiding political action

Medical packaging companies in pharmaceutical contract manufacturing

Pharma packaging solutions, design and companies

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief